PKM and cancer: PKM2 expression supports the survival of cancers under acute oxidative stress by promoting anti-oxidant responses, whereas PKM2 activators compromise both pro-anabolic and anti-oxidant functions of cancer cells by increasing PKM2 activity thus interfering with its metabolism.